Cargando…
ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma
ST2 is a member of the IL-1 receptor family and IL-33 was recently identified as its natural ligand. The IL-33/ST2 pathway regulates Th1/Th2 immune responses in autoimmune and inflammatory conditions, but the role of ST2 signaling in tumor growth and metastasis has not been investigated. We aimed to...
Autores principales: | Jovanovic, Ivan, Radosavljevic, Gordana, Mitrovic, Maja, Lisnic Juranic, Vanda, McKenzie, Andrew N J, Arsenijevic, Nebojsa, Jonjic, Stipan, Lukic, Miodrag L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746127/ https://www.ncbi.nlm.nih.gov/pubmed/21484786 http://dx.doi.org/10.1002/eji.201141417 |
Ejemplares similares
-
IL-33/ST2 axis in innate and acquired immunity to tumors
por: Jovanovic, Ivan P., et al.
Publicado: (2012) -
Deletion of IL-33R (ST2) Abrogates Resistance to EAE in BALB/C Mice by Enhancing Polarization of APC to Inflammatory Phenotype
por: Milovanovic, Marija, et al.
Publicado: (2012) -
Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma
por: Milosavljevic, Milos Z., et al.
Publicado: (2016) -
Differential Immunometabolic Phenotype in Th1 and Th2 Dominant Mouse Strains in Response to High-Fat Feeding
por: Jovicic, Nemanja, et al.
Publicado: (2015) -
Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?
por: Borovcanin, Milica Milovan, et al.
Publicado: (2017)